Oct 12 (Reuters) - Cryo-Cell International Inc CCEL.A :
* CORD BLOOD BANKING LEADER CRYO-CELL REPORTS FISCAL THIRD
QUARTER
2023 FINANCIAL RESULTS
* CRYO-CELL INTERNATIONAL INC - CURRENTLY FUNDING COMPLETION
OF A
PHASE 2 AUTISM TRIAL AND EXPECT TO BEGIN A PHASE 3 CP TRIAL IN
FIRST HALF OF 2024
* CRYO-CELL INTERNATIONAL INC - REPORTED NET INCOME FOR
THREE
MONTHS ENDED AUGUST 31, 2023 OF $681,000, OR $0.08 PER BASIC
SHARE AND DILUTED SHARE
Source text for Eikon: ID:nBw60XSQYa
Further company coverage: CCEL.A
((Reuters.Briefs@thomsonreuters.com;))